TNF potentiates anticancer activity of bortezomib (Velcade®) through reduced expression of proteasome subunits and dysregulation of unfolded protein response-Reference-Cited by-同舟云学术

TNF potentiates anticancer activity of bortezomib (Velcade®) through reduced expression of proteasome subunits and dysregulation of unfolded protein response

Published:2007 Issue:2 Volume:121 Page:431-441
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Nowis Dominika,McConnell Elizabeth J.,Dierlam Lindsey,Palamarchuk Alla,Lass Agnieszka,Wójcik Cezary

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction

2. Proteasome Inhibitor Drugs on the Rise: Figure 1.

3. The development of proteasome inhibitors as anticancer drugs

4. Proteasome inhibitors: from research tools to drug candidates

5. Apoptosis induced in L1210 leukaemia cells by an inhibitor of the chymotrypsin-like activity of the proteasome

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New lead compounds identification against KRas mediated cancers through pharmacophore-based virtual screening and in vitro assays;Journal of Biomolecular Structure and Dynamics;2022-10-02

2. Alternative splicing: An important regulatory mechanism in colorectal carcinoma;Molecular Carcinogenesis;2021-02-25

3. Changes in spatio-temporal localization of tripeptidyl peptidase II (TPPII) in murine colon adenocarcinoma cells during aggresome formation: a microscopy study based on a novel fluorescent proteasome inhibitor;HISTOL HISTOPATHOL;2019

4. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo;Cancer Biology & Therapy;2017-07-11

5. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy;Molecular Cancer;2017-05-12